what is glp-1 injections Decoding Weight Loss Medications The Latest on GLP-1s |
Description
Week 1 to 4: Initial adaptation
Effects of exendin-4, a glucagon like peptide-1 receptor agonist, on neutrophil count and inflammatory cytokines in a rat model of endotoxemia
Should a GLP-1 (Glucagon-like peptide-1) receptor agonist, such as semaglutide (generic name) or tirzepatide (generic name), be continued or discontinued in a patient who has achieved a BMI reduction from 30 to 22?
Tirzepatide is currently the most potent weight-lowering drug approved
doi: 10.1016/j.jacc.2020.05.037 38 DaviesMJDAlessioDAFradkinJKernanWNMathieuCMingroneGet al
:max_bytes(150000):strip_icc()/Health-GettyImages-2112991930-7aba42b37c8641d3a76cb03100b26dda.jpg)
With adjustments as needed for the patient's specific health needs
